Yale School of Management

Srikant M. Datar; David A. Garvin; James  Weber

Case | HBS Case Collection | February 2008 (Revised February 2008)

Yale School of Management

by Srikant M. Datar, David A. Garvin and James Weber

Abstract

In the fall of 2006, the Yale School of Management launched a new core curriculum in its MBA program. The new curriculum eliminated traditional discipline-based courses such as finance and marketing and replaced them with courses that sought to integrate teaching and learning across functions and from the perspective of the constituents with whom leaders typically interacted, such as customers, competitors, and investors. This case examines the implementation of the new curriculum and how it transformed business education at the Yale School of Management.

Keywords: Transformation; Business Education; Curriculum and Courses; Learning; Teaching; Integration;

Format: Print

26 pages

Find at Harvard

Citation:

Datar, Srikant M., David A. Garvin, and James Weber. "Yale School of Management." Harvard Business School Case 308-011, February 2008. (Revised February 2008.)

We describe how Coronary Artery Bypass Grafting (CABG, or more popularly, “bypass”) operations revolutionized the treatment of coronary disease (that can produce fatal heart attacks and debilitating angina). Specifically we chronicle the 1) development of the foundational procedures and technologies that provided a base for CABG; 2) early CABG operations performed in the 1960s; 3) rapid—and controversial growth—that occurred in the U.S. in the 1970s and; 4) emergence and rapid diffusion of the less invasive angioplasty alternative that slowed the growth of CABG in the last two decades of the 20th century.

We describe how Computed Tomography (CT) scanners—that combine x-rays and computers to image soft tissues of the brain and other organs—have become a widely used diagnostic tool. Specifically, we chronicle the following: 1) development of the first CT scanner (through the early 1970s); 2) rapid and enthusiastic adoption of CT scanning (until the late 1970s); 3) regulatory backlash against the perceived overuse of this expensive technology (in the 1980s); and 4) innovations that reignited growth (in the 1990s and 2000s).

We describe how a chance discovery of bacteria that infects stomach linings completely changed how physicians treat ulcers. Specifically, we chronicle how 1) two Australian physicians brought the bacterial infection to the world’s attention and challenged the conventional view that stomach acidity caused ulcers; 2) a global community of researchers helped corroborate the Australians’ findings and developed convenient tests and effective treatments; and 3) these tests and treatments were gradually, but not immediately, adopted.

Faculty & Research

Yale School of Management

Abstract

Citation:

About the Author

More from the Author